Search For "dr sharvil patel"
25 Years of Listing on NSE - Zydus Lifesciences Limited
Updated : 10 months, 2 weeks ago IST
Mumbai (Maharashtra) [India], May 3: To commemorate the 25th year of the listing of Zydus Lifesciences Ltd. (formerly known as Cadila Healthcare Ltd.) on the National Stock Exchange of India (NSE), a bell ringing ceremony was organized at BKC, Mumbai on 2nd May 2025. On this occasion, senior
Read More
Zydus Launches IBYRA, the Generic Version of Olaparib, Brings Both Access
Updated : 2 years ago IST
Ahmedabad (Gujarat) [India], March 14: In a significant stride towards making advanced cancer treatment accessible to all, Zydus has launched Olaparib, a PARP inhibitor, under the brand name IBYRA in India. The drug will target specific genetic mutations prevalent in certain types of cancers
Read More
Zydus Lifesciences Q2 Net Profit up by 53% Y-o-Y
Updated : 2 years, 4 months ago IST
Ahmedabad (Gujarat) [India], November 7: Zydus Lifesciences Ltd. announced its unaudited consolidated financial results for the quarter and half year ended September 30th, 2023.
Read More
Will take another 4-5 months to publish phase 3 trials data of ZyCoV-D vac
Updated : 4 years, 6 months ago IST
New Delhi [India], August 21 (ANI): Managing Director of Zydus Group Dr Sharvil Patel on Saturday said that his firm will soon apply for the Indian drug regulator's approval to conduct trials of ZyCoV-D on children above 2 years and added that it will take another 4-5 months to publish the p
Read More
More clarity on ZyCOV-D vaccine price by next week, says Zydus Group MD Sh
Updated : 4 years, 6 months ago IST
New Delhi [India], August 21 (ANI): There will be more clarity on the price of its COVID-19 vaccine ZyCOV-D by next week, said Managing Director of Zydus Group Dr Sharvil Patel on Saturday.
Read More
Zydus Cadila seeks nod for its COVID-19 vaccine ZyCoV-D, aims to produce 1
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): The pharmaceutical firm Zydus Cadila on Thursday informed that it has applied for emergency use authorisation (EUA) from the Drug Controller General of India (DCGI) for its DNA vaccine ZyCoV-D against coronavirus disease and stated that they expect to produce
Read More